Back
Pitney Bowes 10K Form
Buy
59
PBI
Pitney Bowes
Last Price:
7.51
Seasonality Move:
4.83%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-02 | 10Q | PBI/Pitney Bowes Quarterly |
2024-02-20 | 10K | PBI/Pitney Bowes Annual |
2023-11-02 | 10Q | PBI/Pitney Bowes Quarterly |
2023-08-03 | 10Q | PBI/Pitney Bowes Quarterly |
2023-05-05 | 10Q | PBI/Pitney Bowes Quarterly |
2023-02-17 | 10K | PBI/Pitney Bowes Annual |
Receive PBI News And Ratings
See the #1 stock for the next 7 days that we like better than PBI
PBI Financial Statistics
Sales & Book Value
Annual Sales: | $3.27B |
---|---|
Cash Flow: | $71.72M |
Price / Cash Flow: | 12.04 |
Annual Sales: | $-2.39 |
Price / Book: | 0 |
Profitability
EPS (TTM): | -1.50000 |
---|---|
Net Income (TTM): | $-264.11M |
Gross Margin: | $1.09B |
Return on Equity: | 0% |
Return on Assets: | -6.2% |
Pitney Bowes Earnings Forecast
Key Pitney Bowes Financial Ratios
- The Gross Profit Margin over the past 40 years for PBI is 33.23%.
- The Selling, General & Administrative Expenses for PBI have been equal to 27.47% of Gross Profit Margin.
- The Research & Development expenses have been 1.27% of Revenue.
- The Interest Expense is -42.46% of Operating Income.
- The Net Earning history of PBI is -11.81% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 22 years.
Pitney Bowes Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Commercial Services & Supplies |
Sector: | Industrials |
Current Symbol: | PBI |
CUSIP: | 724479 |
Website: | pitneybowes.com |
Debt
Debt-to-Equity Ratio: | -4.96 |
---|---|
Current Ratio: | 0.96 |
Quick Ratio: | 0.85 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 7.69 |
PBI Technical Analysis vs Fundamental Analysis
Buy
59
Pitney Bowes (PBI)
is a Buy
Is Pitney Bowes a Buy or a Sell?
-
Pitney Bowes stock is rated a Buy
The current Pitney Bowes [PBI] share price is $7.50. The Score for PBI is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.